Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DB26FX4CR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $69,441
Award facts
- Contract value 100% obligated
- $69,440.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $69,440.98 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes on October 30, 2025, with an ultimate completion date of October 31, 2025. This firm fixed-price contract, which was not set-aside, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, supplies a comprehensive range of medical products to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. Dupixent is a specialty biologic medication used to treat conditions such as atopic dermatitis, asthma, and eosinophilic conditions, representing the type of specialized pharmaceutical commodity that AmerisourceBergen delivers through its extensive federal contract portfolio with the DLA's Medical Supply Chain. The competitively awarded delivery order demonstrates the contractor's capability to fulfill federal procurement requirements for critical specialty medications supporting military healthcare programs.
Quick answers
Who was awarded contract SPE2DB26FX4CR?
SPE2DB26FX4CR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DB26FX4CR worth?
The government has obligated $69,441 on SPE2DB26FX4CR.
Is contract SPE2DB26FX4CR an order under another contract?
Yes. SPE2DB26FX4CR is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB26FX4CR competed?
The extent of competition for SPE2DB26FX4CR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award